Notice of Expiration for PA-18-627 NIDA Academic Research Enhancement Award (R15 Clinical Trial Required)

Notice Number: NOT-DA-19-018

Key Dates
Release Date: January 10, 2019

Related Announcements
PA-18-627

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to announce the expiration of PA-18-627 NIDA Academic Research Enhancement Award (R15 Clinical Trial Required) effective January 8, 2019. There are no plans to reissue this PA.

NIDA is participating in four other R15 Funding Opportunity Announcements (FOA) and encourages eligible institutions to submit appropriate R15 applications under one of those FOAs. These include:

  • PAR-18-714 Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Not Allowed)
  • PAR-19-133 Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required)
  • PAR-19-135 Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
  • PAR-19-134 Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)

The FOA has been modified to read:

Part 1. Overview Information

Key Dates

Expiration Date

January 10, 2019

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Tracy Waldeck, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-827-5844
Email: tracy.waldeck@nih.gov